Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours.
- DOI
- 10.1186/s12885-018-4745-3
- Published
- 2018 Aug 29
- Container
- BMC cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-018-4745-3,
title = {Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours.},
author = {Lawrence NJ and Chan H and Toner G and Stockler MR and Martin A and Yip S and Wong N and Yeung A and Mazhar D and Pashankar F and Frazier L and McDermott R and Walker R and Tan H and Davis ID and Grimison P and ANZUP},
year = {2018},
journal = {BMC cancer},
doi = {10.1186/s12885-018-4745-3},
url = {https://doi.org/10.1186/s12885-018-4745-3}
}RIS
TY - JOUR TI - Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours. AU - Lawrence NJ AU - Chan H AU - Toner G AU - Stockler MR AU - Martin A AU - Yip S AU - Wong N AU - Yeung A AU - Mazhar D AU - Pashankar F AU - Frazier L AU - McDermott R AU - Walker R AU - Tan H AU - Davis ID AU - Grimison P AU - ANZUP PY - 2018 JO - BMC cancer DO - 10.1186/s12885-018-4745-3 UR - https://doi.org/10.1186/s12885-018-4745-3 ER -
APA
NJ, L., H, C., G, T., MR, S., A, M., S, Y., N, W., A, Y., D, M., F, P., L, F., R, M., R, W., H, T., ID, D., P, G., & ANZUP (2018). Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours.. BMC cancer. https://doi.org/10.1186/s12885-018-4745-3
Source records
- pubmed · retrieved 2026-09-27T11:13:06.835Z